Clearmind Medicine Inc (CMND)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 10/31
| 07-2024 | 04-2024 | 01-2024 | 10-2023 | 07-2023 | |
| Operating Expenses | 1,471 | 1,304 | 1,384 | 1,712 | 1,103 |
| Operating Income | -1,471 | -1,304 | -1,384 | -1,712 | -1,103 |
| Interest Expense | 61 | 0 | 0 | 0 | 0 |
| Other Income | -519 | 432 | 218 | -2,347 | 521 |
| Pre-tax Income | -2,051 | -872 | -1,166 | -4,058 | -582 |
| Income Tax | 43 | 37 | 202 | 11 | -7 |
| Net Income Continuous | -2,094 | -908 | -1,368 | -4,070 | -575 |
| Net Income | $-2,094 | $-908 | $-1,368 | $-4,070 | $-575 |
| EPS Basic Total Ops | -23.60 | -11.20 | -36.00 | 50.80 | -97.20 |
| EPS Basic Continuous Ops | -23.53 | -11.17 | -36.07 | 46.73 | -97.37 |
| EPS Diluted Total Ops | -23.60 | -11.20 | -36.00 | 50.80 | -97.20 |
| EPS Diluted Continuous Ops | -23.53 | -11.17 | -36.07 | 46.73 | -97.37 |
| EPS Diluted Before Non-Recurring Items | -23.60 | -11.20 | -36.00 | N/A | N/A |
| EBITDA(a) | $-1,468 | $-1,300 | $-1,381 | $-1,708 | $-1,094 |